Beranda › Limfoma Hodgkin › California

Uji klinis Limfoma Hodgkin di California

15 studi untuk Limfoma Hodgkin mencari peserta di lokasi di California.

Kota di California

Teks studi resmi (Bahasa Inggris)

Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma

City of Hope Cancer Center (Data Collection Only), Duarte
Stanford University Medical Center, Stanford

Menerima pesertaFase 2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT03618550

Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma

City of Hope, Duarte

Menerima pesertaFase 1

Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT05798897

AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.

Research Site, Duarte

Menerima pesertaFase 1/2

Usia 12 ke atas · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT06137144

Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma

City of Hope Comprehensive Cancer Center, Duarte
University of California Davis Comprehensive Cancer Center, Sacramento

Menerima pesertaFase 1

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT05272384

ctDNA-Guided Therapy for Relapsed/Refractory Hodgkin Lymphoma

University of California Davis, Davis
University of California San Francisco-Fresno, Fresno
University of California Irvine, Irvine
dan 3 lainnya

Menerima pesertaFase 2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 20 Agu 2026 · NCT07021989

A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant

City of Hope Medical Center, Duarte

Menerima pesertaFase 1Sukarelawan sehat diterima

Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 28 Jul 2026 · NCT07020533

Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial

Chao Family Comprehensive Cancer Center, University of California Irvine, Orange

Menerima pesertaFase 2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Jul 2026 · NCT06580002

Brentuximab Vedotin in Early Stage Hodgkin Lymphoma

Stanford University - (Stanford Cancer Institute), Stanford

Menerima pesertaFase 3

Usia 16 hingga 69 · Semua jenis kelamin · Diperbarui 8 Jul 2026 · NCT04685616

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

City of Hope, Duarte
Children's Hospital of Los Angeles, Glendale
Scripps Green Hospital, La Jolla
dan 8 lainnya

Menerima pesertaStudi observasional

Semua usia · Semua jenis kelamin · Diperbarui 6 Jul 2026 · NCT01351545

Patient-Reported Outcomes and Quality of Life in Adult and Pediatric Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)

Stanford University Medical Center, Palo Alto

Menerima pesertaStudi observasional

Usia 8 ke atas · Semua jenis kelamin · Diperbarui 20 Mei 2026 · NCT06098430

A Study of Carmustine With and Without Ethanol in Subjects With Lymphoma

City of Hope National Medical Center, Duarte

Menerima pesertaFase 2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 27 Mar 2026 · NCT06915246

CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant

City of Hope Medical Center, Duarte

Menerima pesertaFase 2Sukarelawan sehat diterima

Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 10 Mar 2026 · NCT06059391

Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma and Hodgkin's Disease

Stanford University School of Medicine, Stanford

Menerima pesertaStudi observasional

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Des 2025 · NCT00398177

Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma

City of Hope Medical Center, Duarte

Menerima pesertaFase 2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 4 Des 2025 · NCT04871607

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Children's Hospital Los Angeles, Los Angeles
Children's Hospital Orange County, Orange
UCSF School of Medicine, San Francisco

Menerima pesertaFase 1

Usia 1 hingga 21 · Semua jenis kelamin · Diperbarui 6 Des 2024 · NCT05476770

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.